Aldosterone receptor antagonists: Diuretics for heart failure

References

Citations

1. Pitt B, et al. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine, 341(10): 709–717.

2. Heart Failure Society of America (2006). HFSA 2006 comprehensive heart failure practice guidelines: Executive summary. Journal of Cardiac Failure, 12(1): 10–38. Also available online: http://www.abouthf.org/guidelines.htm.

3. Pitt B, et al. (2003). Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine, 348(14): 1309–1321.

Author:	Robin Parks, MS	Last Updated: September 1, 2006
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Stephen Fort, MD, MRCP, FRCPC - Interventional Cardiology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.